TrialJournal of diabetes investigation2016

Efficacy and safety of ipragliflozin in Japanese patients with type 2 diabetes stratified by body mass index: A subgroup analysis of five randomized clinical trials.

Atsunori Kashiwagi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.